Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 04:58 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » Canadian Stock Picks » Watch: Levon Resumes(LVN.V) Phase 4 Drilling at Cordero



Reply
 
Thread Tools Search this Thread
Old 10-01-2013, 09:38 AM   Nav to Top  #1
stockmountie
Senior Trader
 
stockmountie's Avatar
 
Join Date: Oct 2011
Location: Canada
Posts: 485
Favorites: SSH.V CZH.V EDW.V
Rep Power: 119
Reputation: 66
stockmountie will become famous soon enough
Default Levon Resumes(LVN.V) Phase 4 Drilling at Cordero

Levon Resumes(LVN.V) Phase 4 Drilling at Cordero






VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 1, 2013) - Levon Resources Ltd. ("Levon" or "the Company") (TSX:LVN)(BERLIN:LO9)(FRANKFURT:LO9) is pleased to report resumption of Phase 4 drilling at the Company's wholly owned Cordero project. An initial 14,000 metres of core drilling is planned to test the recently acquired Aida claim, (announced August 15, 2013) located in a central part of the Cordero resource. Levon's purchase of the Aida claim consolidates the Company's ownership of 100% of the mineral rights in the district. The current Indicated mineral resource at Cordero includes 364 million (M) oz of Ag, 945,000 oz of Au, 6.1 billion (B) lbs of Zn, and 3.3B lbs of Pb [contained metal] (US $6 NSR cutoff grade was used, calculated at $25/oz Ag, $1.00/lb Zn and Pb. Gold was included in the tabulations based on areas within the resource which have higher gold grades). The indicated plus inferred resources are described in Levon's updated resource report (as amended May 10, 2013) for the Cordero Project completed by Independent Mining Consultants in collaboration with M3 Engineering and Technology of Tucson, AZ. (view at www.Sedar.com or www.Levon.com.)

The Cordero project is a bulk tonnage Ag, Au, Zn, Pb project located in Chihuahua State, Mexico, 35 km northeast of the town of Hidalgo Del Parral.

Levon is well funded for the exploration now underway as summarized in the company's Annual Report and financials available on the Company's website at www.Levon.com.

Qualified Person

Levon's projects are under the direct supervision of Vic Chevillon, MA, CPG, and Vice President of Exploration for Levon who is a qualified person (AIPG C.P.G #11054) within the context of National Instrument 43-101 and has read and takes responsibility for this News Release.

About Levon Resources

Levon is a gold and precious metals exploration Company, exploring the Cordero bulk tonnage silver, gold, zinc, and lead project near Hidalgo Del Parral, Chihuahua, Mexico. The Company also holds interests in three mineral properties located in British Columbia, Canada, and three mineral properties located in Nevada, USA.

ON BEHALF OF THE BOARD
stockmountie is offline   Rate this post Yes | No Reply With Quote
Old 10-15-2014, 08:14 AM   Nav to Top  #2
stockmountie
Senior Trader
 
stockmountie's Avatar
 
Join Date: Oct 2011
Location: Canada
Posts: 485
Favorites: SSH.V CZH.V EDW.V
Rep Power: 119
Reputation: 66
stockmountie will become famous soon enough
Thread Starter
Default Levon Resources Ltd.(TSX:LVN) Acquires 9.9% of Pershing Gold

Levon Resources Ltd.(TSX:LVN) Acquires 9.9% of Pershing Gold




TSX Trading Symbol: LVN
Berlin & Frankfurt: LO9
OTCQX: LVNVF

VANCOUVER, Oct. 15, 2014 /PRNewswire/ - Levon Resources Ltd. (the Company) TSX:LVN, USOTCQX: LVNVF is pleased to announce it has agreed to make an investment into Pershing Gold Corporation ("Pershing") in the amount of US $9.85 million, acquiring 35,178,572 shares of common stock of Pershing, representing an approximate 9.9% interest in Pershing. The transaction is expected to close on or about October 17, 2014. Pershing's common stock is traded on the OTCQB under the symbol PGLC.

The common shares have not been registered under the United States Securities Act of 1933, as amended, or any applicable state securities laws and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the foregoing securities in any jurisdiction, including in the United States, in which such offer, solicitation or sale would be unlawful.

About Levon Resources Ltd.

Levon is a gold and precious metals exploration Company, exploring the company's 100% owned flagship Cordero bulk tonnage silver, gold, zinc, and lead project near Hidalgo Del Parral, Chihuahua, Mexico
stockmountie is offline   Rate this post Yes | No Reply With Quote
Old 10-24-2014, 08:09 AM   Nav to Top  #3
stockmountie
Senior Trader
 
stockmountie's Avatar
 
Join Date: Oct 2011
Location: Canada
Posts: 485
Favorites: SSH.V CZH.V EDW.V
Rep Power: 119
Reputation: 66
stockmountie will become famous soon enough
Thread Starter
Default Levon Resources Ltd.(TSX:LVN) Announces a USD $1 Million Private Placement

Levon Resources Ltd.(TSX:LVN) Announces a USD $1 Million Private Placement




VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 24, 2014) - Levon Resources Ltd. (the Company) (TSX:LVN)(OTCQX:LVNVF)(BERLIN: LO9)(FRANKFURT:LO9) is pleased to announce it is undertaking a USD $1 million private placement (the "Placement").

A total of 4,400,000 common shares of Levon will be issued in the Placement at a price of CAD $0.25 per share. To Levon's knowledge, no new insiders of Levon will be created as a result of the Placement. Completion of the Placement is subject to the approval of the Toronto Stock Exchange.

The common shares to be sold in the Placement have not been registered under the United States Securities Act of 1933, as amended, or any applicable state securities laws and may not be offered or sold in the United States unless registered under the Securities Act or pursuant to an exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the foregoing securities in any jurisdiction, including in the United States, in which such offer, solicitation or sale would be unlawful.

About Levon Resources Ltd.

Levon is a gold and precious metals exploration Company, exploring the company's 100% owned flagship Cordero bulk tonnage silver, gold, zinc, and lead project near Hidalgo Del Parral, Chihuahua, Mexico.

ON BEHALF OF THE BOARD

Ron Tremblay, President and Chief Executive Officer
stockmountie is offline   Rate this post Yes | No Reply With Quote
Old 03-20-2015, 08:35 AM   Nav to Top  #4
stockmountie
Senior Trader
 
stockmountie's Avatar
 
Join Date: Oct 2011
Location: Canada
Posts: 485
Favorites: SSH.V CZH.V EDW.V
Rep Power: 119
Reputation: 66
stockmountie will become famous soon enough
Thread Starter
Default Levon Resources Ltd. (TSX:LVN) (OTCQX:LVNVF) Announces Definitive Agreement to Acqui

Levon Resources Ltd. (TSX:LVN) (OTCQX:LVNVF) Announces Definitive Agreement to Acquire SciVac Ltd.




VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 20, 2015) - Levon Resources Ltd. ("Levon") (TSX:LVN)(OTCQX:LVNVF)(BERLIN:LO9)(FRANKFURT:LO9) and SciVac Ltd. ("SciVac") announced today that they have entered into an arrangement agreement pursuant to which Levon will acquire 100% of the issued and outstanding ordinary shares of SciVac by way of a court-approved plan of arrangement (the "Arrangement").

"I am excited to announce this transaction with SciVac, as I believe it will generate tremendous value for Levon shareholders," stated Ron Tremblay, President and Chief Executive Officer of Levon. "In a difficult market for resource issuers, we have chosen to preserve capital while seeking to identify alternatives to create shareholder value. The acquisition of SciVac gives Levon ownership of Sci-B-Vac™, a commercial stage, potentially best in class hepatitis B vaccine which could address a significant market opportunity. Levon shareholders will also maintain an interest in Levon's existing business and assets by receiving shares of a newly formed company which will hold Levon's existing resource assets."

Pursuant to the Arrangement, Levon shareholders will receive one new common share of Levon (each a "New Levon Share") and 0.5 of a common share (each, a "Spinco Share") of 1027949 BC Ltd., a newly formed exploration company ("Spinco") in exchange for each common share of Levon (each a "Levon Share") held by them. Upon closing of the Arrangement, Levon shareholders will hold 100% of the issued and outstanding Spinco Shares and 31.6% of the issued and outstanding New Levon Shares, with the former holders of SciVac Shares holding the remaining 68.4% of the issued and outstanding New Levon Shares. In addition to acquiring all of the issued and outstanding shares of SciVac, Levon will retain CAD $27 million in cash. All other assets and liabilities of Levon will be transferred to or will be assumed by Spinco. At the closing of the Arrangement, Levon expects that in addition to holding all of Levon's mineral properties, including Levon's flagship Cordero Project, SpinCo will have approximately $20.1M in working capital, including approximately $3M in cash, a $1.1M convertible debenture as well as 35,178,572 shares of Pershing Gold Corporation with current estimated value of $16M. SpinCo will also hold a $2M Mexican value added tax receivable that Levon expects will be recovered. The total of 22.1M represents approximately 48% of Levon's working capital as at December 31, 2014.

"SciVac is pleased to announce this transaction with Levon in furtherance of our goal of expanding market opportunities for SciVac products in development, including Sci-B-Vac, our third-generation hepatitis B vaccine," said Dr. Curtis Lockshin, Chief Executive Officer for SciVac. "Sci-B-Vac has already been approved in several countries, including Israel, where it has been provided to hundreds of thousands of newborn children. We intend to pursue marketing approvals for Sci-B-Vac in the United States and other territories worldwide, initially focused on at-risk populations such as End-Stage Renal Disease and HIV patients. In addition, we believe the transaction will permit SciVac to cultivate a pipeline of other therapeutics, utilizing novel treatment approaches in various disease areas with unmet needs."

SciVac is currently a privately owned company, of which approximately 45% of the shares are owned by OPKO Health, Inc. (NYSE:OPK). OPKO's CEO and Chairman, Dr. Phillip Frost, commented, "This transaction with Levon presented an opportunity to unlock meaningful value for OPKO shareholders via OPKO's ownership interest in SciVac. SciVac is a commercial-stage biotech leader in protein engineering whose flagship product, Sci-B-Vac, is a superior next generation hepatitis B vaccine. Sci-B-Vac has received approval for use in ten countries including Israel, where it captures half the market for neonatal hepatitis B vaccinations, and is offered to adults who do not respond to competing hepatitis B vaccines. It appears positioned to expand the billion dollar global hepatitis B vaccine market upon successful completion of the FDA approval process."

The board of directors of Levon has unanimously approved the transaction and all directors and officers of Levon, collectively holding approximately 10.08% of the number of Levon Shares and 76.94% of the number of options to purchase Levon Shares (the "Levon Options") anticipated to be entitled to vote at a special meeting to consider the Arrangement, have agreed to vote in favour of the Arrangement.

Arrangement Details

The Arrangement will be effected by way of a court-approved plan of arrangement and will require the approval of at least 2/3 of the votes cast by Levon's shareholders and optionholders at a special meeting expected to take place in April 2015 (the "Meeting"). The transaction is also subject to applicable regulatory approvals, including approval of the TSX, and the satisfaction of certain closing conditions customary in transactions of this nature.

The Arrangement will result, through a series of transactions, in:
•Levon shareholders receiving one New Levon Share and 0.5 of a Spinco Share for each Levon share currently held by them;
•holders of SciVac Shares receiving that number of New Levon Shares representing 68.4% of the issued and outstanding New Levon Shares in exchange for the acquisition by Levon of all of the issued and outstanding SciVac Shares;
•the change of Levon's name to "SciVac Inc."; and
•the change of Spinco's name to "Levon Resources Ltd."

Holders of outstanding Levon stock options may exercise their options until the effective time of the Arrangement, at which time they will be cancelled.

On completion of the Arrangement, Spinco will own and operate the existing business of Levon and Levon will own and operate the existing business of SciVac. Levon shareholders who receive New Levon Shares and Spinco Shares under the Arrangement will hold 100% of the issued and outstanding Spinco Shares and 31.6% of the issued and outstanding New Levon Shares, with the former holders of SciVac Shares holding the remaining 68.4% of the issued and outstanding New Levon Shares.

After taking into consideration, among other things, the terms of the Arrangement, the unanimous recommendation of a special committee of Levon directors established to review the Arrangement and discussions with its legal and financial advisors, Levon's board of directors has unanimously concluded that the Arrangement is in the best interests of Levon and has approved the Arrangement. Levon's board of directors intends to recommend in the management information circular to be mailed in connection with the Meeting that Levon's shareholders and optionholders vote in favour of the Arrangement.

Subject to SciVac's right to match, Levon's board of directors may terminate the arrangement agreement in favour of an unsolicited superior proposal upon payment of a US$1 million break fee to SciVac.

Advisors

Levon's legal counsel is Stikeman Elliott LLP and Dorsey & Whitney LLP. Cassel Salpeter & Co., LLC is Levon's financial advisor.

About Levon Resources Ltd.

Levon is a gold and precious metals exploration Company, exploring the company's 100% owned flagship Cordero bulk tonnage silver, gold, zinc, and lead project near Hidalgo Del Parral, Chihuahua, Mexico.

About SciVac Ltd.

SciVac Ltd., headquartered in Rehovot Israel, is in the business of developing, producing and marketing biological products for human healthcare. SciVac's flagship product Sci-B-Vac is a recombinant 3rd generation hepatitis B vaccine. SciVac also offers contract development and manufacturing services to the life sciences and biotechnology markets.

ON BEHALF OF THE BOARD

Ron Tremblay, President and Chief Executive Officer
stockmountie is offline   Rate this post Yes | No Reply With Quote
Old 03-31-2015, 11:41 AM   Nav to Top  #5
stockmountie
Senior Trader
 
stockmountie's Avatar
 
Join Date: Oct 2011
Location: Canada
Posts: 485
Favorites: SSH.V CZH.V EDW.V
Rep Power: 119
Reputation: 66
stockmountie will become famous soon enough
Thread Starter
Default Levon Resources Ltd.(TSX: LVN) (FRANKFURT: LO9) (OTCQX: LVNVF) Announces Definitive

Levon Resources Ltd.(TSX: LVN) (FRANKFURT: LO9) (OTCQX: LVNVF) Announces Definitive Agreement to Acquire SciVac Ltd.




VANCOUVER, BC--(Marketwired - March 20, 2015) - Levon Resources Ltd. ("Levon") (TSX: LVN) (FRANKFURT: LO9) (OTCQX: LVNVF) and SciVac Ltd. ("SciVac") announced today that they have entered into an arrangement pursuant to which Levon will acquire 100% of the issued and outstanding ordinary shares of SciVac by way of a court-approved plan of arrangement (the "Arrangement").

"I am excited to announce this transaction with SciVac, as I believe it will generate tremendous value for Levon shareholders," stated Ron Tremblay, President and Chief Executive Officer of Levon. "In a difficult market for resource issuers, we have chosen to preserve capital while seeking to identify alternatives to create shareholder value. The acquisition of SciVac gives Levon ownership of Sci-B-Vac™, a commercial stage, potentially best in class hepatitis B vaccine which could address a significant market opportunity. Levon shareholders will also maintain an interest in Levon's existing business and assets by receiving shares of a newly formed company which will hold Levon's existing resource assets."

Pursuant to the Arrangement, Levon shareholders will receive one new common share of Levon (each a "New Levon Share") and 0.5 of a common share (each, a "Spinco Share") of 1027949 BC Ltd., a newly formed exploration company ("Spinco") in exchange for each common share of Levon (each a "Levon Share") held by them. Upon closing of the Arrangement, Levon shareholders will hold 100% of the issued and outstanding Spinco Shares and 31.6% of the issued and outstanding New Levon Shares, with the former holders of SciVac Shares holding the remaining 68.4% of the issued and outstanding New Levon Shares. In addition to acquiring all of the issued and outstanding shares of SciVac, Levon will retain CAD $27M in cash. All other assets and liabilities of Levon will be transferred to or will be assumed by Spinco. At the closing of the Arrangement, Levon expects that in addition to holding all of Levon's mineral properties, including Levon's flagship Cordero Project, SpinCo will have approximately $20.1M in working capital, including approximately $3M in cash, a $1.1M convertible debenture as well as 35,178,572 shares of Pershing Gold Corporation with current estimated value of $16M. SpinCo will also hold a $2M Mexican value added tax receivable that Levon expects will be recovered. The total of $22.1M represents approximately 48% of Levon's working capital as at December 31, 2014.

"SciVac is pleased to announce this transaction with Levon in furtherance of our goal of expanding market opportunities for SciVac products in development, including Sci-B-Vac, our third-generation hepatitis B vaccine," said Dr. Curtis Lockshin, Chief Executive Officer for SciVac. "Sci-B-Vac has already been approved in several countries, including Israel, where it has been provided to hundreds of thousands of newborn children. We intend to pursue marketing approvals for Sci-B-Vac in the United States and other territories worldwide, initially focused on at-risk populations such as End-Stage Renal Disease and HIV patients. In addition, we believe the transaction will permit SciVac to cultivate a pipeline of other therapeutics, utilizing novel treatment approaches in various disease areas with unmet needs."

SciVac is currently a privately owned company, of which approximately 45% of the shares are owned by OPKO Health, Inc. (NYSE: OPK). OPKO's CEO and Chairman, Dr. Phillip Frost, commented, "This transaction with Levon presented an opportunity to unlock meaningful value for OPKO shareholders via OPKO's ownership interest in SciVac. SciVac is a commercial-stage biotech leader in protein engineering whose flagship product, Sci-B-Vac, is a superior next generation hepatitis B vaccine. Sci-B-Vac has received approval for use in ten countries including Israel, where it captures half the market for neonatal hepatitis B vaccinations, and is offered to adults who do not respond to competing hepatitis B vaccines. It appears positioned to expand the billion dollar global hepatitis B vaccine market upon successful completion of the FDA approval process."

The board of directors of Levon has unanimously approved the transaction and all directors and officers of Levon, collectively holding approximately 10.08% of the number of Levon Shares and 76.94% of the number of options to purchase Levon Shares (the "Levon Options") anticipated to be entitled to vote at a special meeting to consider the Arrangement, have agreed to vote in favour of the Arrangement.

Arrangement Details

The Arrangement will be effected by way of a court-approved plan of arrangement and will require the approval of at least 2/3 of the votes cast by Levon's shareholders and optionholders at a special meeting expected to take place in April 2015 (the "Meeting"). The transaction is also subject to applicable regulatory approvals, including approval of the TSX, and the satisfaction of certain closing conditions customary in transactions of this nature.
The Arrangement will result, through a series of transactions, in:
•Levon shareholders receiving one New Levon Share and 0.5 of a Spinco Share for each Levon share currently held by them;
•holders of SciVac Shares receiving that number of New Levon Shares representing 68.4% of the issued and outstanding New Levon Shares in exchange for the acquisition by Levon of all of the issued and outstanding SciVac Shares;
•the change of Levon's name to "SciVac Inc."; and
•the change of Spinco's name to "Levon Resources Ltd."

Holders of outstanding Levon stock options may exercise their options until the effective time of the Arrangement, at which time they will be cancelled.

On completion of the Arrangement, Spinco will own and operate the existing business of Levon and Levon will own and operate the existing business of SciVac. Levon shareholders who receive New Levon Shares and Spinco Shares under the Arrangement will hold 100% of the issued and outstanding Spinco Shares and 31.6% of the issued and outstanding New Levon Shares, with the former holders of SciVac Shares holding the remaining 68.4% of the issued and outstanding New Levon Shares.

After taking into consideration, among other things, the terms of the Arrangement, the unanimous recommendation of a special committee of Levon directors established to review the Arrangement and discussions with its legal and financial advisors, Levon's board of directors has unanimously concluded that the Arrangement is in the best interests of Levon and has approved the Arrangement. Levon's board of directors intends to recommend in the management information circular to be mailed in connection with the Meeting that Levon's shareholders and optionholders vote in favour of the Arrangement.

Subject to SciVac's right to match, Levon's board of directors may terminate the arrangement agreement in favour of an unsolicited superior proposal upon payment of a US$1 million break fee to SciVac.

Advisors

Levon's legal counsel is Stikeman Elliott LLP and Dorsey & Whitney LLP. Cassel Salpeter & Co., LLC is Levon's financial advisor.

About Levon Resources Ltd.

Levon is a gold and precious metals exploration Company, exploring the company's 100% owned flagship Cordero bulk tonnage silver, gold, zinc, and lead project near Hidalgo Del Parral, Chihuahua, Mexico.

About SciVac Ltd.

SciVac Ltd., headquartered in Rehovot Israel, is in the business of developing, producing and marketing biological products for human healthcare. SciVac's flagship product Sci-B-Vac is a recombinant 3rd generation hepatitis B vaccine. SciVac also offers contract development and manufacturing services to the life sciences and biotechnology markets.

ON BEHALF OF THE BOARD
Ron Tremblay
President and Chief Executive Officer
stockmountie is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: VIPR - WKN: A0NEFW - VIPR Industries Signs Exploration Contract to Commence Drilling Bulldogs11 US Penny Stock Picks 0 04-04-2011 07:10 PM
Strong Sell: Drilling their way to “Major Player” status StentorMedia Canadian Stock Picks 0 02-23-2011 06:03 PM
Strong Buy: PDS - Precision Drilling Trust (USA) BulloverBear US Stock Picks 2 09-10-2009 11:40 AM
WHO increases pandemic alert to phase 6 Germs Rumors & News 0 06-11-2009 01:48 PM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On